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Abstract 
 
Background: The acetylation state of histones has been used as an indicator of the 
developmental state of progenitor and differentiating cells. The goal of this study was to 
determine the nuclear localization patterns of Class I histone deacetylases (HDACs) in retinal 
progenitor cells (RPCs) and retinal ganglion cells (RGCs), as the first step in understanding their 
potential importance in cell fate determination within the murine retina. Results: The only HDAC 
to label RPC nuclei at E16 and P5 was HDAC1. In contrast, there was generally increased 
nuclear localization of all Class I HDACs in differentiating RGCs. Between P5 and P30, SOX2 
expression becomes restricted to Müller glial, cholinergic amacrine cells, and retinal astrocytes. 
Cholinergic amacrine showed a combination of changes in nuclear localization of Class I 
HDACs. Strikingly, although Müller glia and retinal astrocytes, express many of the same genes, 
P30 Müller glial cells showed nuclear localization only of HDAC1, while retinal astrocytes were 
positive for HDACs 1, 2, and 3. Conclusion: These results indicate there may be a role for one 
or more of the Class I HDACs in retinal cell type-specific differentiation. 
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1. Introduction 
The retina is a highly ordered neural tissue that converts light into neural signals, which are 
transmitted to the brain where they are interpreted as vision. Throughout retinal development, 
the timing and patterns of cellular differentiation are regulated, in part, by the hierarchical 
expression of various gene regulatory networks. Combinatorial expression of eyefield 
transcription factors, including PAX6, RAX, SIX6, and LHX2, demarcate the eye field within the 
anterior neural plate, thereby conferring the competence for formation of ocular structures 
(Tetreault et al., 2009; Zuber et al., 2003). During embryogenesis, multipotent retinal progenitors 
within the retinal neuroepithelium undergo progressive restriction in their competence to 
generate the seven basic cell types of the mature retina: rod and cone photoreceptors, 
amacrine, bipolar, horizontal and retinal ganglion cells, and Müller glia (Wong and Rapaport, 
2009). PAX6 is an early competence factor that appears to be important the generation of all 
retinal cell types (with the exception of amacrine cells) that functions upstream of bHLH factor 
ATOH7 (Brown et al., 2001; Brzezinski et al., 2005; Marquardt et al., 2001; Wang et al., 2001). 
Competence for early born cell types, such as cone photoreceptors, horizontal, and retinal 
ganglion cells, is thought to be conferred by the zinc finger transcription factor IKAROS, 
whereas late born cell types appear to require activity of DICER to process micro RNAs that are 
critical for differentiation of rods, bipolar cells, and Müller glia (Elliott et al., 2008; Georgi and 
Reh, 2010; Iida et al., 2011; La Torre et al., 2013).  
Differentiation of progenitors into the different types of retinal neurons and Müller glia occurs in 
a sequential, but temporally overlapping pattern and requires expression of various transcription 
factors such as selective Sry-related high mobility group box (SOX) factors and proneural basic 
helix-loop-helix (bHLH) factors, which function as competence factors (Graw, 2010; Hufnagel et 
al., 2010; Jiang et al., 2013; Mu et al., 2005; Phillips et al., 2014; Riesenberg et al., 2009; 
Taranova et al., 2006; Yang et al., 2003; Young, 1985). Mice in which Sox4 and Sox11 were 
both knocked out showed a loss of retinal ganglion cells and a decrease in the expression of 
later differentiation factor BRN3b expression (Jiang et al., 2013). SOX2 and 11 appear to 
operate independently of bHLH factors in that knock out animals showed normal Atoh7 
expression levels. SOX2 has also been proposed as a competence factor, however it seems to 
act more as a general competence factor for retinal progenitor cells (Elliott et al., 2008; 
Taranova et al., 2006). Expression of several bHLH genes has also been shown to confer 
competence on retinal ganglion cells, primarily Atoh7 (Brzezinski et al., 2012; Maurer et al., 
2014; Mu et al., 2008; Mu et al., 2005), NeuroD1 (Kiyama et al., 2011; Mao et al., 2008b) and 
Ngn2 (Matter-Sadzinski et al., 2005). These bHLH transcription factors regulate the earliest of 
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RGC-specific transcription factors, POU4F1-3 (BRN3A-C) and other RGC-specific genes that 
are critical for differentiation, defining RGC subpopulations, and ultimately, RGC connectivity 
and function (Gan et al., 1996; Mao et al., 2008a; Matter-Sadzinski et al., 2005; Mu et al., 2008). 
There have been significant advances in understanding the roles of the transcriptional 
regulatory networks and signaling pathways in retinal development and the establishment of 
competence. However, other factors, such as chromatin organization, also play critical roles in 
both competence restriction of progenitor cells and differentiation of cells from the progenitor 
population (Cvekl and Mitton, 2010; Eberhart et al., 2013; Schmalenberger, 1980; Solovei et al., 
2009; Song et al., 2014; Van Bortle and Corces, 2013). At the most basic level, chromatin is 
organized into transcriptionally active euchromatin and inactive heterochromatin (Solovei et al., 
2016). This organization can be modified by changes in methylation patterns within genomic 
CpG islands and/or by post-translational modifications of histone core and tail domains 
(Mersfelder and Parthun, 2006). To date, the best studied examples of these histone 
modifications are acetylation, methylation, phosphorylation, and ubiquitination (Rousseaux and 
Khochbin, 2015). Although a case can be made for differential effects of site-dependent 
acetylation in chromatin regulation, increased histone acetylation is generally associated with 
gene activation (Haberland et al., 2009).  
Histone acetylation is regulated by two families of enzymes with antagonistic roles: histone 
acetyl transferases (HATs) add acetyl groups to specific lysine residues, whereas histone 
deacetylases (HDACs) are responsible for their removal (Chen et al., 2015). HDACs are 
subdivided into the zinc-dependent classical HDACs (HDACs 1-11) and NAD+ dependent 
sirtuins (SIRT1-7). These two groups are further subdivided into four classes based on 
molecular similarities with yeast homologues (Gregoretti et al., 2004). The zinc-dependent 
classical HDACs constitute Classes I, II, and IV deacetylases, while the NAD+ dependent 
sirtuins constitute the Class III deacetylases (Delcuve et al., 2013). Class I HDACs, including 
HDACs 1, 2, 3 and 8, show predominantly, although not exclusively, nuclear localization, 
whereas Class II HDACs, including HDACs 4-7, 9, and 10, shuttle between the nucleus and 
cytoplasm (Kong et al., 2011). The Class IV HDAC is comprised solely of HDAC 11 and 
appears to be predominantly nuclear (Gao et al., 2002).  
Histone modifications play a key role in regulating chromatin organization and gene expression, 
and have been implicated in modulating the transition from proliferation to differentiation in 
neuronal cells (reviewed by (Jaworska et al., 2015; Reichert et al., 2012)). However, little is 
known about the role of specific HDACs during retinal development. Class I HDACs are of 
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particular interest because they regulate gene expression via recruitment to repressor protein 
complexes within the nucleus, including SIN3, spermatogenic HDAC-interacting protein 1 
(SHIP1), nuclear receptor corepressor (NCoR), silencing mediator for retinoid and thyroid 
receptors (SMRT), nucleosome remodeling deacetylase (NuRD), and RE1-silencing 
transcription factor (REST) complexes (Thomas, 2014).  
There is evidence supporting a critical role of HDACs in regulating differentiation of progenitors 
in the central nervous system (CNS). HDAC1 is involved in multiple processes during 
neurogenesis, including suppression of cell cycle exit, inhibition of WNT and notch signaling, 
regulation of developmental apoptosis and positive regulation of neurogenic genes (Harrison et 
al., 2011; Stadler et al., 2005; Yamaguchi et al., 2005). Trichostatin A inhibition of HDAC activity 
in the neonatal mouse retina increases the extent of normal developmental apoptosis (Wallace 
et al., 2006), and shRNA downregulation of HDAC4 in the postnatal retina results in apoptosis 
of newly differentiated rod photoreceptors and bipolar cells (Chen and Cepko, 2009). Although 
HDACs regulate histone acetylation at a global level within cells, there is some evidence for a 
role in regulating sets of specific genes (Chen and Cepko, 2007; Haberland et al., 2009). A 
potential role for HDACs in regulating cell type-specific programming is suggested by the fact 
that the specificity of each HDAC is dependent upon the binding partners present in the cell. 
The roles of HDACs in the developing mammalian retina have not been fully elucidated. 
Research has primarily focused on the role of these proteins in retinal and CNS diseases. As a 
first step to delineating the role of this critical family of enzymes in retinal development, we 
determined the temporal and cellular expression patterns of Class I HDACs in the developing 
murine retina in retinal progenitor cells and differentiating RGCs. 
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2. Results 
2.1 Acetylated and methylated histone H3 expression in the developing murine retina 
Post-translational modifications of histones have been correlated with relative accessibility of 
chromatin to transcription factors and RNA polymerase complexes. Histone H3 can be either 
acetylated or methylated at lysine 9, with the levels of acetylation vs. methylation respectively 
serving as good predictors of underlying promoter activation vs. silencing (Du et al., 2015; 
Karmodiya et al., 2012). The cellular distribution of acetylated histone H3 at lysine 9 (H3K9ac), 
as a marker of an open chromatin state, and of tri-methylated histone H3 at lysine 9 
(H3K9me3), as a marker of a closed chromatin state (Bannister and Kouzarides, 2011) was 
analyzed by immunostaining across retinal development. Three developmental stages were 
chosen for the study: embryonic day 16 (E16) to represent the early proliferative state of the 
retina, when the retina consists primarily of progenitor cells and early born ganglion and cone 
cells; postnatal day 5 (P5), when the retina contains multiple classes of differentiated neurons 
and late stage proliferating progenitors; and postnatal day 30 (P30), when the retina is fully 
differentiated and no progenitors remain (Young, 1985). In addition to labeling with antibodies 
specific for each Class I HDAC, control sections at each stage were also incubated with isotypic 
IgG in place of the primary antibody (Supplementary Fig 1), as well as with no primary antibody. 
At E16, a subset of nuclei at the scleral edge of the retinal neuroepithelium (Fig 1A: arrows) and 
in the nascent nerve fiber layer (Fig1A: arrowheads) were H3K9ac+. In contrast, H3K9me3 
immunopositive cells were detected throughout the retina (Fig 1B). Cells that were immuno-
positive for the H3K9ac modification were also co-labeled with the H3K9me3 (Fig 1A-C: arrows 
and arrowheads). At P5, H3K9ac was detected in fewer cells, compared to E16, and the 
majority of labeled cells located at the sclerad margin of the retina (Fig 1D). Similar to E16, 
H3K9me3 immunoreactivity continued to be detected in nuclei of essentially all retinal cells, and 
again, cells positive for H3K9ac were co-labeled for H3K9me3 (Fig 1D-F). At P30, the H3K9ac 
modification was not detected within the retina (Fig 1G). In contrast, H3K9me3 was detected in 
nuclei throughout the retina, although the intensity of staining appeared to be reduced 
compared to E16 and P5 (Fig 1H, I).  
 
2.2 Quantitation of Hdac mRNA and protein in developing murine retina 
To further explore the basis for the dynamic patterns of histone acetylation throughout retinal 
development, levels of Class I Hdacs were investigated by RT-qPCR (Fig 2A) and western blot 
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(Fig 2B). Hdac1 showed a small increase in mRNA expression at P5 in comparison to E16, and 
a subsequent decrease at P30. Hdac2 (Fig 2A) expression progressively decreased during 
development, with levels subsequently reduced by 73% at P30 (p=0.001 vs. E16). Hdacs 3 and 
8 levels showed little change across the timepoints examined (Fig 2A). However, apparent 
differences in Hdac1, Hdac3 and Hdac8 mRNA expression did not reach statistical significance.  
Antibodies against the Class I HDACs labeled a single band at the predicted molecular weights 
in whole retinal lysates, confirming specificity of the antibodies in western blotting (Fig 2B). At 
E16, P5 and P30, there were subtle changes in the intensity of the bands that for HDAC1 and 
HDAC2 that followed the general patterns of their transcript levels. HDAC8 protein levels 
appeared to decrease at P30, in comparison to E16 and P5, despite the absence of detectible 
changes in mRNA expression. However, after normalization to β-tubulin controls, none of the 
apparent changes in protein band intensity reached statistical significance. 
 
2.3 Localization of HDACs in differentiating Retinal Ganglion, Cholinergic Amacrine, and Retinal 
Astrocytes in the Developing Murine Retina 
Although overall protein levels did not change considerably throughout retinal development, we 
hypothesized that changes in nuclear HDAC localization could be associated with differentiation 
of specific cell types. To test this idea, comparative analyses were done to determine nuclear 
co-localization of Class I HDACs (HDACs 1, 2, 3, and 8) with (1) a nuclear marker for retinal 
progenitor cells (SOX2) at E16 and P5, (2) a nuclear marker of retinal ganglion cells (RGCs) 
(POU4F1 or 3) at E16, P5 and P30, and (3), Müller glial cells, retinal astrocytes, and a subset of 
cholinergic amacrine cells (SOX2) at P5 and P30 (Tables I and II; Figs 3-6).  
 
2.3a HDAC1 
Early stage retinal progenitors at E16 showed nuclear co-localization of SOX2 and HDAC1 (Fig 
3A; Supplementary Fig 2A, B). In contrast, late stage SOX2+ retinal progenitor nuclei at P5 
were predominantly negative for HDAC1 (Fig 3C; open arrows). An interesting pattern of 
HDAC1 labeling was detected at P5 in a subpopulation of cells at the outer edge of retina (Fig 
3C, D). While we did not co-label these cells for cell type-specific markers, the pattern is similar 
to that observed by other investigators in GABA+ horizontal cells in the developing mouse retina 
(Schubert et al., 2010). At P30, HDAC1 labeled nuclei were present throughout the retina, and 
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included the SOX2+ Müller glia (Fig 3E; open arrows), cholinergic amacrine cells (Fig 5E: 
closed arrows) and retinal astrocytes (Fig 5E: arrowheads). 
RGCs are one of the first class of neurons generated during retinal development and they begin 
to express POU4F transcription factors shortly after exiting cell cycle (Pan et al., 2005). At E16, 
all POU4F+ retinal ganglion cell nuclei were double-labeled for HDAC1, with migrating RGCs 
within the neuroblastic layer, showing less intense labeling than differentiated RGCs in the 
ganglion cell layer (Fig 3B; Supplementary Fig 2C, D: arrows). Mature RGCs continued to have 
robust nuclear staining for HDAC1 at P5 (Fig 3D) and P30 (Fig 3F).  
 
SOX2+ cholinergic amacrine cells (Fig 3C, E: closed arrows) and retinal astrocytes (Fig 3C, E: 
arrowheads) showed co-localization of SOX2 and HDAC1 at both P5 and P30. SOX2+ Müller 
glia also showed HDAC1 nuclear co-localization at P30 (Fig. 3: open arrows). At P5 and P30, 
additional HDAC1 positive/SOX2 negative nuclei were present in the inner nuclear layer and 
likely included additional subtypes of amacrine cells and bipolar cells but were not specifically 
identified using cell type-specific markers in this study. Sections treated with preabsorbed 
antibody (Fig 3G-I) or IgG (Supplementary Fig 1) showed no HDAC label at any of the stages 
examined. 
 
2.3b HDAC2 
Compared to HDAC1, the cellular localization of HDAC2 (Fig. 4) was more variable across 
retinal development, with generally diffuse, punctate staining at E16, robust nuclear staining in 
differentiated neurons in the inner nuclear and ganglion cell layers at P5 and P30. At both E16 
and P5, nuclei of retinal progenitors had little or no colocalization of HDAC2 with SOX2 (Fig. 4A, 
C: open arrows).  
 
At E16, migrating RGCs in the neuroblastic layer also lacked nuclear HDAC2 staining (Fig. 4B: 
open arrows). There was some co-localization of HDAC2 and POU4F immunostaining in RGC 
nuclei in the ganglion cell layer at E16 (Fig. 4B: arrows) that was robust by P5 (Fig. 4D) and P30 
(Fig 4F).  
 
Some of the HDAC2+ nuclei in the ganglion cell layer were identified as presumptive retinal 
astrocytes, based on co-localization with SOX2 at E16, P5 and P30 (Fig. 4A, C, E: arrowheads). 
SOX2+ cholinergic amacrine cells were also HDAC2+ at P5 and P30 (Fig. 4C, E: arrows). At P5 
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and P30, additional cells in the inner nuclear and ganglion cell layers showed robust nuclear 
localization of HDAC2. At P30 HDAC2 was also detected in Müller glial nuclei (Fig 4E: open 
arrows), although not as robustly as in amacrine cells and retinal astrocytes. Very weak, but 
consistent HDAC2 immunolabeling was detected in the outer nuclear layer at P30. Sections 
treated with preabsorbed antibody showed no HDAC2 label at any of the stages examined (Fig 
4G-I). 
2.3c HDAC3 
Overall, HDAC3 expression patterns were similar to HDAC2, with primarily non-nuclear 
immunoreactivity at E16, increased nuclear staining in the inner nuclear and ganglion cell layers 
at P5 and P30. Weak HDAC3 labeling was observed in progenitor nuclei primarily at the sclerad 
edge of the retina at E16 (Fig 5A), whereas only a few scattered SOX2+ progenitor cells were 
co-labeled with HDAC3 at P5 (Fig 5C: open arrows).  
At E16, only a subpopulation of RGCs nuclei, primarily those closest to the vitreous, showed 
weak HDAC3 immunoreactivity, whereas migrating RGCs were HDAC3 negative (Fig 5B; 
Supplementary Fig 3A, B). Nuclear HDAC3 immunoreactivity in RGCs increased at P5 (Fig 5D), 
and was still present at P30 (Fig 5F).  
SOX2+ cholinergic amacrine cells (Fig 5C: closed arrows) and retinal astrocytes (Fig 5C: 
arrowheads) showed distinct nuclear localization of HDAC3, but only at P5 (Fig 5C). By P30, no 
HDAC3 label was present in Müller glial cells (Fig 5E; open arrows), HDAC3 label was present 
in the nuclei of cholinergic amacrine cells (Fig 5E; Supplementary Fig 3C, D: arrows in INL), and 
strong label was still apparent in the nuclei of retinal astrocytes (Fig 5E: arrowheads; 
Supplementary Fig 3C, D: arrows in GCL). Sections treated with preabsorbed antibody showed 
no HDAC3 label at any of the stages examined (Fig 5G-I). 
2.3d HDAC8 
HDAC8 immunoreactivity was primarily non-nuclear at E16 and P5. SOX2+ progenitor nuclei 
were devoid of HDA 8 signals at both E16 (Fig 6A) and P5 (Fig 6C: open arrows). 
Comparatively, RGC nuclei were consistently, albeit weakly positive for HDAC8 at E16 and P5 
(Fig 6B, D; Supplementary Fig 4: arrows), but no HDAC8 immunostaining was present in RGC 
nuclei at P30 (Fig 6F). At P5, cholinergic amacrine cells (Fig 6C: arrows) and retinal astrocytes 
(Fig 6C: arrowheads) showed some nuclear co-labeling for SOX2 and HDAC8 (Supplementary 
Fig 5: arrows). Consistent with the low levels of HDAC8 levels seen in western blots, P30 retina 
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showed no detectable HDAC8 immunoreactivity (Fig 6E, F). Sections treated with preabsorbed 
antibody showed little HDAC8 label at any of the stages examined (Fig 6G-I). 
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3. Discussion 
We observed dynamic changes in cellular patterns and sub-cellular localization of the different 
Class I HDACs during retinal development, despite only minor changes in total HDAC mRNA or 
protein levels (summarized in Tables 1 and 2). Of the HDACs analyzed, all showed at least 
some level of both nuclear and non-nuclear localization across developmental timepoints. 
HDAC1 was the only Class I HDAC that showed a primarily nuclear localization in early stage 
retinal progenitors, as well as in differentiated cells with in the inner nuclear and ganglion cell 
layers. In contrast, distinctly nuclear localization of HDAC2 and 3 was not detected in retinal 
progenitors, but was present in differentiated cells in the inner nuclear and ganglion cell layers 
at P5 and P30. HDAC8 was predominantly non-nuclear at E16 and P5, and was not detected 
by immunofluorescence at P30. Theoretically, a change in nuclear localization during key 
points of differentiation may indicate HDACs that are critical to the chromosomal organization 
that accompanies the loss of progenitor characteristics and/or the gain of differentiative 
characteristics.  
 
While we focused primarily on nuclear localization of the HDACs, we noted in analyzing the 
data that each also showed cytoplasmic localization at one or more stages of development. 
Class I HDACs have widely been described as having predominantly nuclear localization (Barry 
and Townsend, 2010; Yano et al., 2018; Zahnow et al., 2016). However, careful review of the 
literature indicates that this most likely is not true and that Class I HDACs may have cell- or 
tissue-specific functions that require cytoplasmic localization (Guo et al., 2015; Hou et al., 
2014; Seto and Yoshida, 2014; Takase et al., 2013; Waltregny et al., 2004; Yao and Yang, 
2011). There was substantial label found in the inner plexiform layer for each of the HDACs at 
one or more stages with the exception of HDAC3. It is of interest to note that the inner 
plexiform layer is a synaptic area comprised primarily of axons and dendrites from bipolar, 
amacrine, and ganglion cells. HDAC1 and 2 are localized to post-synaptic densities in 
dendrites in many regions of the brain (Takase et al., 2013). HDACs 3 and 8 are also localized 
to post-synaptic densities, but in fewer regions of the brain than 1 and 2. HDAC2 has also been 
described in the hippocampus as having both nuclear and/or cytoplasmic localization, 
depending the stage examined (Hou et al., 2014).   
 
A few of the timepoints we examined showed a low correlation between protein and mRNA 
levels (for instance HDAC8 levels at P30). While there can be good correlation between mRNA 
and protein level, particularly when protein half-life is short (Raj et al., 2006), evidence from 
other literature suggests the mRNA level is not predictive of protein level (Liu et al., 2016; 
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Taniguchi et al., 2010). There are many reasons why there may not be a relationship between 
mRNA and protein levels. For instance, post-transcriptional modifications (PTMs) such as 
micro RNAs can regulate degradation of mRNAs and reduce translation of proteins (Fabian et 
al., 2010). In addition, protein level can be affected by PTMs that alter protein half-life. While 
most investigators associate HDACs with reversal of a PTM to other proteins, HDACs are also 
targets of multiple types of PTMs, such as phosphorylation, methylation, ubiquitination, 
oxidation, sumoylation, nitrosylation, ADP-ribosylation, glycosylation, and carbonylation (Segre 
and Chiocca, 2011). Class I HDACs have much greater enzymatic activity than other HDACs 
and are also known to target many proteins in addition to histones, and so it has been 
proposed that both of these characteristics may be regulated by PTMs (Eom and Kook, 2014). 
Furthermore, Class I HDACs are known to be degraded in a PTM-dependent fashion (Adenuga 
et al., 2009; Choi et al., 2015; Park and Juhnn, 2017; Segre and Chiocca, 2011). 
 
3.1 H3K9 acetylation in the retina 
Histone acetylation is typically associated with open chromatin structure and active gene 
transcription. In embryonic stem (ES) cells, inhibition of H3K9 deacetylation maintains 
expression of pluripotency genes and blocks neuronal differentiation (Qiao et al., 2015). In 
contrast, H3K9 di- and tri-methylation is associated with silencing of pluripotency genes in 
neuroprogenitors derived from ES cells (Golebiewska et al., 2009). Therefore, it was 
unexpected that few retinal progenitors at E16 or P5 were stained for acetylated H3K9, whereas 
essentially all progenitors were stained for H3K9-me3. Early stage retinal progenitors had 
clearly detectible nuclear localization of HDAC1 throughout the neuroblastic layer at E16. Thus, 
it is likely that at least some level of active histone deacetylation occurs in neural retinal 
progenitors. Nevertheless, acetylation of other lysine residues on multiple histone proteins (e.g. 
H3K14, H4K8) is also associated with transcriptional activation and pluripotency (Agalioti et al., 
2002). Because these other patterns of acetylation would not be detected using H3K9-ac 
specific antibodies used in our study, overall levels of histone acetylation in retinal progenitors is 
likely higher than our immunostaining would suggest. A recent study showed that 4 days of 
pharmacological inhibition of HDAC1 in P1 retinal explants increased H3K9 and H4K12 
acetylation in both the inner and outer retina, although these studies did not analyze earlier 
timepoints (Ferreira et al., 2017). Thus, further studies will be required to determine the patterns 
and functional significance other histone acetylation and methylation motifs in early stage retinal 
progenitors.  
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3.2 Class I HDACs in retinal progenitors 
In the retina, SOX2, a SOXB1-HMG box transcription factor, is required to keep retinal 
progenitors in the cell cycle and SOX2 expression is down-regulated as progenitors exit the cell 
cycle and differentiate (Taranova et al., 2006). Both Class I and Class III HDACs have been 
implicated in regulating SOX2 expression (Kondo and Raff, 2004; Lyssiotis et al., 2007; 
Staszkiewicz et al., 2013). Most HDACs repress SOX2 transcription in neural progenitors 
(Lyssiotis et al., 2007; Wang et al., 2015) and loss of HDAC2 activity, in particular, has been 
associated with an increase in SOX2 expression (Conway et al., 2012; Jawerka et al., 2010). 
We observed little to no expression of HDAC2, 3 or 8 in early stage retinal progenitors. 
Interestingly, HDAC1 had a distinctly nuclear localization in SOX2+ early stage retinal 
progenitors. In ES cells, HDAC1 and HDAC2 are required for positive regulation of several 
pluripotency genes and the promoters of Oct4, Nanog and Sox2 are physically occupied by 
HDAC1 (Kidder and Palmer, 2012; Saunders et al., 2017). Thus, the expression of HDAC1 and 
absence of HDAC2 in early stage retinal progenitors could reflect a novel, HDAC2-independent 
role for HDAC1 in positive regulation of SOX2. Consistent with the idea that HDAC1 is 
compatible with SOX2 expression, HDAC1 was the only Class I HDAC that co-labeled SOX2+ 
Müller glial cells at P30.  
HDACs also regulate cell cycle progression and the G1 to S phase transition is blocked in 
Hdac1 -/- mice (Lagger et al., 2002), or by general inhibition of HDAC activity by suberoylanilide 
hydroxamic acid (SAHA) and sodium butyrate (Zhou et al., 2011). A more targeted study of 
HDAC1 and 2 in hematopoiesis indicates that they may function in both cell cycle progression 
and differentiation (Wilting et al., 2010). There is also evidence that HDAC1 knockout leads to 
increased levels of p21 and p27, as well as decreased levels of cyclins A and E in the embryo 
(Lagger et al., 2002). Interestingly, conditional knockout of both HDAC1 and HDAC2 in ES cells 
results in defects in chromosomal segregation during mitosis and a general cessation of 
proliferation, followed by cell death (Jamaladdin et al., 2014). This points to a critical role for 
HDAC1 and HDAC2 in mitosis, apart from their regulation of the G1 to S transition. Consistent 
with this, HDAC1 inhibition in post-natal retinal explants decreases BrdU incorporation (Ferriera 
2017). The robust nuclear expression of HDAC1 in early-stage retinal progenitors could reflect 
an additional role in maintaining proliferative capacity and expression of genes associated with 
multipotency.  
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When results of HDAC inhibition are considered in the context of the complementary expression 
patterns of HDAC1 and H3K9ac, these data suggest that histone deacetylation by HDAC1 plays 
an active role in retinal progenitors. Interestingly, pharmacological inhibition of HDAC1 in P1 
retinal explants also increases expression of some retinal progenitor and cell cycle associated 
genes (e.g. Hes1, Vsx2, Ccnd1), and decreases expression of rod photoreceptor-specific genes 
(e.g. rhodopsin, Nrl, Pde6b) (Ferriera 2017). Thus, it is tempting to speculate that changes in 
histone acetylation and HDAC1 expression in early vs. late stage progenitors contribute to 
developmental changes in their neurogenic competence. 
 
3.3 Class I HDACs in differentiating neurons 
Histone deacetylation plays a key role in regulating expression of pluripotency genes and the 
switch towards neural differentiation, but the mechanisms by which HDACs regulate 
proliferation and/or differentiation have been studied in tissues other than the retina. In 
differentiating RGCs at E16, nuclear HDAC1 immunoreactivity progressively increased in post-
mitotic retinal ganglion cells as they migrated towards the ganglion cell layer. In contrast, overall 
levels of HDAC2 and 3 in differentiating retinal ganglion cells were much lower at E16. 
Nevertheless, HDAC1, HDAC 2 and HDAC3 all showed robust nuclear staining in neurons 
located in both the inner nuclear and ganglion cell layers at P5, again pointing to a role for 
histone deacetylation in differentiation of retinal neurons. HDAC1, 2, and 3 expression was also 
fairly robust in the ganglion cell layer at P30, suggesting that continued expression of these 
HDACs may be required for maintenance of neuronal differentiation. 
 
3.4 Class I HDACs in retinal glia 
There appear to be cell-type specific roles for HDACs in neurogenesis vs. gliogenesis. For 
example, HDAC inhibition blocks neurogenesis and promotes gliogenesis by neural progenitors 
derived from embryonic ganglionic eminence, but has the opposite effect on neural progenitors 
from the embryonic cortex (Shaked et al., 2008). We observed that all 4 Class I HDACs were 
expressed in the nuclei of retinal astrocytes at P5 and HDAC1, 2, and 3 were present at P30. 
However, only HDAC1 was present in Müller glia. These two cell types are derived from 
different lineages, with astrocytes migrating into the retina from progenitors located in the optic 
stalk (Chan-Ling and Stone, 1991; Otteson et al., 1998; Zhang and Stone, 1997). We previously 
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showed that the SOX2+ astrocyte precursors in the optic nerve also express HDACs 1, 2 and 3 
at E16 (Tiwari et al., 2014). In contrast, Müller glia are the progeny of retinal progenitors and 
share lineage relationship with retinal neurons. Interestingly, Müller glia express many of the 
same genes as retinal progenitors and show limited stem-cell characteristics in the mammalian 
retina following injury and growth factor stimulation (Beach et al., 2017; Bernardos et al., 2007; 
Goldman, 2014; Otteson et al., 2001; Otteson and Phillips, 2010; Vihtelic and Hyde, 2000; Yao 
et al., 2018). A recent study showed that overexpression of activated β-catenin and CRX/NRL 
induced Müller glia to reenter the cell cycle and generate new rod photoreceptors in the 
absence of injury, further supporting the stem cell-like characteristics of Müller glia (Yao et al., 
2018).  The expression of HDAC1 in both Müller glia and early-stage retinal progenitors may be 
reflect the shared characteristics of these cells.  
In conclusion, the expression patterns of Class I HDACs were consistent with the idea that 
these proteins may play significant roles in the differentiation of neurons and glia within the 
retina. The robust and continued expression of HDACs 1, 2, and 3 in differentiated neurons is 
likely to reflect important roles in the maturation, maintenance of differentiation, and cellular 
functions of multiple cell-types within the retina. Future studies will be directed at inhibition 
and/or knockout of specific HDACs at multiple stages during retinal development to determine 
their role in the specification, differentiation and maintenance of other retinal cell types. The 
potential role of other classes of HDACs also need to be considered in retinal differentiation 
and/or maintenance; however, inhibition of Class III HDACs had minimal effect on H3K9, H3K27 
or H4K12 acetylation in retinal explants (Ferreira et al., 2017). Deacetylation by HDACs can 
regulate function of multiple proteins inside and outside the nucleus in other tissues (Li et al., 
2014), and it will undoubtedly be informative to identify additional HDAC substrates and their 
functions in the retina. Finally, histone methylation, which is closely associated with histone 
deacetylation by HDACs, also needs further clarification in its role in retinal differentiation. 
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4. Materials and Methods 
4.1 Animals used in the study and tissue harvest  
All experiments in this study conformed to the guidelines from the National Institutes of Health 
Guide for the Care and Use of Laboratory Animals, Eighth Edition (NIH Publications No. 8023) 
and were approved by the IUPUI School of Science IACUC. C57BL/6J mice from Jackson Labs 
(Bar Harbor, ME) were maintained on a 12 hour light/dark cycle and mated within the facility. 
For embryonic tissue, the date of vaginal plug was designated as 0.5 days post coitum. Whole 
heads from embryonic day 16 (E16) and eyes from postnatal stages (P5) were fixed between 
1:00 and 3:00pm using 4% paraformaldehyde in 0.1 M phosphate buffer, pH 7.4 at 4°C 
overnight. P30 eyes were fixed in 4% paraformaldehyde in 0.1M cacodylate buffer (pH 7.4) for 1 
hour at 4°C. Tissue was then rinsed in phosphate buffered saline (PBS: potassium chloride 200 
mg/L, potassium phosphate 200 mg/L, sodium chloride 8000 mg/L, and sodium phosphate 1150 
mg/L), pH 7.5 and infiltrated with a gradient of sucrose in 0.1 M phosphate buffer, from 5% to 
20% over 4 days. Eyes were frozen a 3:1 ratio of 20% sucrose in 0.1 M phosphate buffer to 
Optimal Cutting Temperature (OCT; Sakura Finetek USA Inc) solution and retinal sections cut 
twelve microns (Leica CM3050 S cryostat) were mounted on charged glass slides (Superfrost 
plus™) and stored at -70°C.  
 
4.2 Immunohistochemistry 
Concentrations of primary and secondary antibodies used in this study are listed in the Key 
Resources Table. Immunohistochemistry was performed as described in Tiwari et al. (Tiwari et 
al., 2014). Briefly, slides with cryosections were post-fixed using 4% paraformaldehyde (30 min, 
room temperature). Slides were rinsed in PBS and permeabilized with methanol (10 min), 
followed by antigen retrieval (1% SDS in 0.01M PBS) for 5 min. To reduce autofluorescence, 
slides were incubated in 1% sodium borohydride (Acros, New Jersey) in PBS (2-5 min). Non-
specific binding was blocked by incubation in PBS containing 0.25% TritonX-100 (Biorad, 
Hercules, CA) and 10% normal donkey serum (30 min). Primary antibodies were diluted in PBS 
with 2% donkey serum, 0.025% TritonX-100 and incubated overnight at 4°C. Secondary 
antibodies were Alexa-fluor conjugated (Donkey anti-rabbit 549 and Donkey anti-mouse 546; 
Invitrogen) or DyLight conjugated (Donkey anti-goat 488; Jackson ImmunoResearch) were 
applied for 1 hr. Counterstaining for nuclei was performed using 2µg/ml of Hoechst Stain (Cat# 
H1399, Invitrogen). Slides were coverslipped by using Aquamount (Cat#18606-20, 
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Polysciences Inc; Warrington, PA). Slides were imaged using an Olympus Confocal FV 1000 
microscope. Each antibody label was analyzed on sections through at least 3 separate eyes at 
each stage.  
To test the specificity of the primary antibodies used, some sections were stained using 
antibodies pre-absorbed with specific peptides (sourced from antibody supplier or made by 
Thermofisher) to each HDAC antibody. Each antibody was preabsorbed with the relevant 
peptide for one hour before applying to the tissue of interest. To test for non-specific 
background staining of the secondary antibody, IgG controls were done wherein tissue sections 
were incubated with the IgG of the host (Thermofisher) in which the primary antibody was made 
(Supplementary Figure 1), in place of the primary antibody incubation. Subsequent steps of the 
immunostaining procedures peptide and IgG controls followed the standard protocol both 
described above.  
 
4.3 Western blot analysis  
Immunoblotting was performed as described in Tiwari et al using antibodies at the 
concentrations described in Key Resources Table (Tiwari et al., 2014). Briefly, retinas from 
three stages of development (E16, P5 and P30) were lysed in lysis buffer (5M NaCl, 1M Tris pH 
8.0, 0.5 M EDTA, 5% TritonX-100), containing protease inhibitor cocktail (cOmplete™; Roche) 
and 1 mM phenylmethanesulfonylfluoride (PMSF), and quantified using bicinchoninic acid 
assays (Pierce BCA Protein Assay Kit; Thermoscientific) and spectrophotometer (NanoDrop 
2000c; ThermoFisher Scientific) following manufacturer’s instructions. For western blots, 50 µg 
total protein was mixed with the laemmli sample buffer loading dye at 3:1 ratio, incubated at 
65°C for 15 minutes and 50 µg per lane loaded and separated on SDS-PAGE (4-20% gradient 
gel) at 150 V for approximately one hour prior to transfer to polyvinylidene difluoride (PVDF) 
membrane in transfer buffer containing 25mM Tris, 192mM glycine, pH8.3 and 20% methanol. 
Non-specific binding to membranes was blocked for one hour prior to application of antibodies. 
For most antibodies, protein-free blocking buffer (Pierce Protein–Free T20 (TBS) Blocking 
Buffer, Cat# 37571) was used. For antibodies specific to HDAC2 Tris-buffered saline-Tween 
(TBST: 20 mM Tris base, 137 mM sodium chloride, 1 M HCl, 0.1% Tween-20, at pH 7.6) 
containing 5% non-fat dry milk was used for blocking. Membranes were subsequently probed 
using same antibodies as used as used for immunohistochemistry, specific to each of the 
HDACs, diluted in corresponding blocking buffer and incubated overnight at 4°C on a shaker. 
Blots were washed with TBST, followed by incubation with peroxidase-conjugated secondary 
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antibodies (ThermoFisher Scientific) diluted 1:5000 in TBST for 1 hour at room temperature. 
Bands were detected via chemiluminescence (Super Signal West Femto Chemiluminescent 
Substrate; Thermoscientific) and photosensitive film. Antibodies and concentrations used for 
Western blots are listed in Table 3. β-tubulin was used as a loading control. Quantification used 
Image J 1.34 software for densitometry. Statistical analysis used one-way ANOVA, with post-
hoc pairwiseT-tests corrected for multiple comparisons using the Bonferroni method (GraphPad 
Prism software, v5.0; GraphPad Software, Inc., San Diego, CA), with p<0.05 considered 
statistically significant. 
 
4.4 RT-qPCR 
Retinal tissue was isolated from eyes of mice from three stages of development (E16, P5, and 
P30), and preserved with an RNA stabilization reagent (Cat#76104, Qiagen). Tissue samples 
were stored -70oC for no more than 2 months prior to RNA isolation. Total RNA was isolated 
using affinity columns (RNeasyPlus mini kit # 74134; Qiagen) as per manufacturer’s 
instructions, with samples eluted in 40µl of RNAse-free water and stored at -80oC until reverse 
transcription. Total RNA was quantified by spectrophotometry (Nanodrop 2000c; ThermoFisher 
Scientific). cDNA was reverse transcribed from 1µg total RNA (iScript cDNA synthesis kit # 170-
8891; Bio-Rad) using a proprietary blend of oligo(dT) primers and random hexamers, as per 
manufacturers protocol. The sequences and efficiencies of all primer pairs used have been 
previously described (Tiwari et al., 2014). Quantitative PCR reactions were performed in 
triplicate 20µl reactions using SYBR green chemistry (Cat# 04707516001; Roche) in the Light 
Cycle 480 II system (Roche). Cycling conditions were: initial denaturation at 95˚C, 10 minutes 
(min); followed by 40 cycles of 95˚C for 10 seconds (sec), 60˚C for 30 sec, and 72˚C for 30 sec; 
and a final extension of 72˚C for 5 min. Melting curve analysis was performed with each PCR 
reaction to verify single products were generated. Three reference genes were used for 
normalization: β-2 microglobulin (β2m), signal recognition particle 14kDa (Srp14) and succinate 
dehydrogenase complex, subunit A (Sdha) (Tiwari et al., 2014). Relative expression software 
tool-multiple condition solver (REST-MCS (Pfaffl et al., 2002)) was used for data analysis to 
determine relative expression and statistical significance of changes (Tiwari et al., 2014). For 
each timepoint, at least three biological replicates were analyzed by RT-qPCR. 
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Figure Legends 
Figure 1: Localization of acetylated and tri-methylated histone H3 (K9) in murine retina. 
Confocal images of acetylated histone H3 (H3K9ac) and tri-methylated H3 (H3K9me3) and 
Hoechst (blue) triple-label of murine retina at E16 (A-C), P5 (D-F) and P30 (G-I). (A) H3K9ac 
label was found in progenitors at the sclerad edge of the E16 neuroepithelium (arrows) and 
presumptive astrocytes at the vitreal edge of the optic cup (arrowheads) at E16. Non-specific 
label was detected in the sclerad basal laminae at E16 (See Supplementary Figure 5 for 
controls) (D & G) Progenitors at the sclerad edge of the developing retina remain at P5, but no 
label was apparent at P30. (B, C, E, F) H3Kme3 immunolabel was present throughout the E16 
and P5 retina, and co-labeled H3K9ac+ cells. (H & I) H3K9me3 was retained throughout the 
retina at P30, but was weaker than E16 and P5 label. No co-labeled cells were present at P30. 
Scale bar in (A) = 50 µm for A-C. Scale bar in (D) = 50µm scale bar for D-I. Abbreviations: RPE, 
retinal pigmented epithelium; NBL, neuroblast layer; INL, inner nuclear layer; ONL, outer 
nuclear layer; GCL, ganglion cell layer.  
 
Figure 2: mRNA and protein levels of Class I HDACs during retinal development.  
(A) Levels of Hdacs1, 2, 3, and 8 were analyzed using RT-qPCR at E16, P5, and P30 relative to 
E16. All Class I Hdacs were expressed at all stages of developing retina in this study. Bars 
show mean log (2) fold change ± SEM of three biological samples per time point. ***, p = 0.001 
vs. E16. (B) Western blot analysis for Class I HDACs was performed and levels analyzed by 
densitometry using β-tubulin as a loading control. Bars show mean ± SEM of three samples per 
time point. An ANOVA analysis indicated that changes in protein levels did not reach the level of 
statistical significance. 
 
Figure 3: Localization of HDAC1 in developing murine retina. 
Sections from E16 (A, B), P5 (C, D) and P30 (E, F) of developing murine retina were double-
labeled for HDAC1 and SOX2 (A, C, E), POU4F3 (B, D), or POU4F1 (F) to determine nuclear 
colocalization. (C) Open arrows indicate SOX2+ progenitors, closed arrows indicate cholinergic 
amacrine cells, arrowheads indicate retinal astrocytes, and asterisks indicate suspected 
horizontal cells. (E) Open arrows indicate Müller glial cells, closed arrows indicate cholinergic 
amacrine cells, arrowheads represent retinal astrocytes, and asterisks indicate suspected 
horizontal cells. Sections through E16 (G), P5 (H), and P30 (I) retina treated with antibody 
preabsorbed with HDAC1 peptide were devoid of signal. Scale bar in (A) = 50 µm for A-F. Scale 
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bar in (G) = 50µm scale bar for G-I. Abbreviations: RPE, retinal pigmented epithelium; NBL, 
neuroblast layer; INL, inner nuclear layer; ONL, outer nuclear layer; GCL, ganglion cell layer. 
 
Figure 4: Localization of HDAC2 in developing murine retina. 
Sections from E16 (A, B), P5 (C, D) and P30 (E, F) of developing murine retina were double-
labeled for HDAC2 and SOX2 (A, C, E), HDAC2 and POU4F3 (B, D), or HDAC2 and POU4F1 
(F). Open arrows indicate retinal progenitors in A, B, and C. Arrowheads (A) indicate retinal 
astrocytes. (B) Arrowheads designate migrating RGCs, while arrows indicate RGCs in the 
ganglion cell layer (GCL). (C) Closed arrows indicate cholinergic amacrine cells, and 
arrowheads indicate retinal astrocytes. (E) Open arrows indicate Müller glial cells, closed arrows 
show cholinergic amacrine cells, and arrowheads designate retinal astrocytes. Peptide controls 
in which the antibody was preabsorbed with the corresponding peptide was performed (G, H 
and I). Scale bar in (A) = 50 µm for A-F. Scale bar in (G) = 50µm scale bar for G-I. 
Abbreviations: RPE, retinal pigmented epithelium; NBL, neuroblast layer; INL, inner nuclear 
layer; ONL, outer nuclear layer; GCL, ganglion cell layer; OPL, outer plexiform layer; IPL, inner 
plexiform layer.  
 
Figure 5: Localization of HDAC3 in developing murine retina. 
Sections from E16 (A, B), P5 (C, D) and P30 (E, F) of developing murine retina were double-
labeled for HDAC3 and SOX2 (A, C, E), or HDAC3 and POU4F3 (B, D), or HDAC3 and 
POU4F1 (F). (C) Open arrows indicate SOX2+ progenitors, closed arrows indicate cholinergic 
amacrine cells, and arrowheads indicate retinal astrocytes. (E) Open arrows indicate Müller glial 
cells, closed arrows indicate cholinergic amacrine cells, and arrowheads represent retinal 
astrocytes. Peptide controls in which the antibody was preabsorbed with the corresponding 
peptide was performed (G, H and I). Scale bar in (A) = 50 µm for A-F. Scale bar in (G) = 50µm 
scale bar for G-I. Abbreviations: RPE, retinal pigmented epithelium; NBL, neuroblast layer; INL, 
inner nuclear layer; ONL, outer nuclear layer; GCL, ganglion cell layer; OPL, outer plexiform 
layer; IPL, inner plexiform layer. 
 
Figure 6: Localization of HDAC8 in developing murine retina. 
Sections for E16 (A, B), P5 (C, D) and P30 (E, F) of developing murine retina were double-
labeled for HDAC8 and SOX2 (A, C, E), or HDAC 8 and POU4F3 (B, D), or HDAC8 and 
POU4F1 (F) to determine nuclear co-localization. (C) Open arrows indicate SOX2+ progenitors, 
closed arrows indicate cholinergic amacrine cells, and arrowheads indicate retinal astrocytes. 
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Peptide controls in which the antibody was preabsorbed with the corresponding peptide was 
performed (G, H and I). Scale bar in (A) = 50 µm for A-F. Scale bar in (G) = 50µm scale bar for 
G-I. Abbreviations:  RPE, retinal pigmented epithelium; NBL, neuroblast layer; INL, inner 
nuclear layer; ONL, outer nuclear layer; GCL, ganglion cell layer; OPL, outer plexiform layer; 
IPL, inner plexiform layer. 
 
Supplementary Figure 1: IgG negative controls. 
To determine non-specific binding of secondary antibodies, sections from E16 (A, D), P5 (B, E), 
and P30 (C, F) retina were reacted with isotypic IgG in place of primary antibody followed by 
fluorescently conjugated secondary antibodies. Scale bar in (A) = 50µm scale bar for A-D. 
 
Supplementary Figure 2: Channel separated enlarged views of HDAC1.  
Sections through E16 murine retina were double-labeled for HDAC1 (A) and SOX2 (B) or 
HDAC1 (C) and POU4F3 (D). Arrows indicate cells that were co-labeled, while arrowheads 
indicate cells that were labeled for HDAC1 (A, C), but not for the accompanying cell type-
specific label (B, D). Scale bar in (A) = 50µm scale bar for A-D. 
 
Supplementary Figure 3: Channel separated enlarged views of HDAC3. 
Sections through E16 (A, B) or P30 (C, D) murine retina were double-labeled for HDAC3 (A) 
and POU4F3 (B) or HDAC3 (C) and SOX2 (D). Arrows indicate cells that were co-labeled, while 
arrowheads indicate cells that were labeled for HDAC3 (C), but not for SOX2 (D). Scale bar in 
(A) = 50µm scale bar for A-D. 
 
Supplementary Figure 4: Channel separated enlarged views of HDAC8 at E16 and P5. 
Sections through E16 (A, B) or P5 (C, D) murine retina were double-labeled for HDAC8 (A, C) 
and POU4F3 (B, D). Arrows indicate cells that were co-labeled. Scale bar in (A) = 50µm scale 
bar for A-D. 
 
Supplementary Figure 5: Channel separated enlarged views of HDAC8 at P30.  
Sections through P5 murine retina were double-labeled for HDAC8 (A) and SOX2 (B). Arrows 
indicate cells that were co-labeled. Scale bar in (A) = 50µm scale bar for A-B. 
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List of Abbreviations 
ANOVA  analysis of variance 
ARVO   Association for Research in Vision and Ophthalmology 
BCA  bicinchoninic acid  
bHLH   basic helix-loop-helix 
CNS   central nervous system 
ES  cells embryonic stem cells  
E16  embryonic day 16 
GABA  gamma-Aminobutyric acid 
GCL  ganglion cell layer 
H3K9ac  acetylated histone H3 at lysine 9 
H3K9me3 tri-methylated histone H3 at lysine 9 
H3K14  histone H3 lysine 14 
H4K8  histone H4 lysine 8 
H4K12  histone H4 lysine 12 
HATs   histone acetyl transferases  
HDACs  histone deacetylases 
INL  inner nuclear layer 
IPL  inner plexiform layer 
IUPUI   Indiana University Purdue University at Indianapolis 
min   minutes 
mRNA  messenger ribonucleic acid 
NAD  nicotinamide adenine dinucleotide 
NBL  neuroblast layer 
NCoR  nuclear receptor corepressor 
NuRD  nucleosome remodeling deacetylase 
OCT   Optimal Cutting Temperature 
ONL  outer nuclear layer 
OPL  outer plexiform layer 
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P5  postnatal day 5 
P30  postnatal day 30 
PBS   phosphate buffered saline 
PMSF   phenylmethanesulfonylfluoride 
PVDF   polyvinylidene difluoride 
REST  RE1-silencing transcription factor complex 
REST-MCS Relative expression software tool-multiple condition solver  
RGCs   retinal ganglion cells  
RPCs   retinal progenitor cells 
RPE  retinal pigmented epithelium 
RT-qPCR reverse transcriptase-quantitative polymerase chain reaction 
SAHA   suberoylanilide hydroxamic acid 
SDS-PAGE sodium dodecyl sulfate polyacrylamide gel electrophoresis 
sec   seconds 
SHIP1  spermatogenic HDAC-interacting protein 1 
SIRT   NAD+ dependent sirtuins 
SMRT  silencing mediator for retinoid and thyroid receptors  
TBST   Tris-buffered saline-Tween 
W  West 
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Table 1: Change in nuclear localization 
between NPC and RGCs at the same stage 
 E16 P5 
HDAC 
NPCs 
SOX2   
GCs 
POU4F 
NPCs 
SOX2 
GCs 
POU4F 
HDAC1 + ++ - + 
HDAC2 - +/- - ++ 
HDAC3 +/- +/- +/- ++ 
HDAC8 - + - + 
NPCs; neural progenitor cells, GCs; ganglion cells 
+ weak nuclear colocalization, ++ strong nuclear colocalization, +/- mixed nuclear colocalization, - no 
nuclear colocalization 
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Table 2: Localization of classical HDACs in nuclei of retinal cell 
types 
HDAC 
AMs (SOX2) Astros (SOX2) 
GCs 
(POU4F) 
MGs 
(SOX2) 
 P5 P30 P5 P30 P5 P30 P30 
HDAC1 + ++ + ++ + ++ + 
HDAC2 ++ + ++ ++ + ++ - 
HDAC3 + + + ++ ++ ++ - 
HDAC8 + - + - + - - 
GCs; ganglion cells, AMs; amacrine cells, Astros; astrocytes, PhRs; photoreceptors, MGs; Müller Glia 
+ weak colocalization, ++ strong colocalization, +/- mixed colocalization, - no colocalization 
Blue- no or slight change 
Green expression levels went up 
Red-expression levels went down 
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tyr; used with tyramide amplification, N/A, not applicable 
 
Antibody Source Antibody Dilution Peptide Supplier 
IHC Westerns 
Rabbit Anti-HDAC1 (Cat# LS-B6094,  
RRID:AB_10944903) 
Life Span Biosciences (Seattle, 
WA) 
1:200 1:2500 Abcam (Cambridge, MA) 
Mouse Anti-HDAC2 (Cat# ab12169,  
RRID:AB_2118547) 
ABCAM (Cambridge, MA) 1:350 1:2500 Abcam (Cambridge, MA) 
Rabbit Anti-HDAC3 
(Cat#3949,   RRID:AB_2118371) 
Cell Signaling (Danvers, MA) 1:300 1:2500 Abcam (Cambridge, MA) 
Rabbit Anti-HDAC8 (Cat# LS-B967, 
RRID:AB_2116942) 
Life Span Biosciences (Seattle, 
WA) 
1:300 1:1000 Life Span Biosciences 
Mouse anti-BRN3A ( Millipore Cat# 
MAB1585, RRID:AB_94166) 
Millipore 1:100 
1:500 (tyr) 
N/A N/A 
 Rabbit anti-BRN3A (Cat#ab81213;  
RRID:AB_1640222) 
Abcam (Cambridge, MA) 1:100 N/A N/A 
Goat anti-BRN3C (Cat# sc-6026, 
RRID:AB_673441) 
Santa cruz  1:100 N/A N/A 
Mouse Anti-methylated histone (Cat# ab1220, 
RRID:AB_449854) 
ABCAM (Cambridge, MA) 1:1000 (tyr) N/A N/A 
Rabbit Anti-Acetylated histone H3 K9 (Cat# 
ab12179, RRID:AB_298910) 
Cell Signaling (Danvers, MA) 1:100 1:2000 N/A 
Goat Anti-SOX2 (Cat# sc17320, 
RRID:AB_2286684) 
Santa Cruz (Santa Cruz, CA) 1:250 N/A Santa Cruz (Santa Cruz, CA) 
Mouse Anti SOX2 (Cat# ab75485, 
RRID:AB_1278243) 
ABCAM (Cambridge, MA) 1:100 N/A Abcam (Cambridge, MA)) 
Mouse anti-β-tubulin (Cat# T0198, 
RRID:AB_477556) 
SIGMA (St. Louis, MO) N/A 1:1000 N/A 
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Highlights 
• Dynamic changes in subcellular localization of Class I HDACs was observed, despite 
relatively minor changes in levels of mRNA or protein 
 
• Very few retinal progenitors were positive for acetylated H3K9, a marker of open 
chromatin and active gene transcription, whereas most retinal progenitors were positive 
for tri-methylated H3K9. 
 
• HDAC1 was the only Class I HDAC localized to the nucleus of retinal progenitors and 
differentiated retinal ganglion cells 
 
• HDACs 2 and 3 were not detected in retinal progenitor nuclei, but were present in inner 
nuclear layer and ganglion cell layer nuclei. 
 
• Class I HDACs may play significant roles in the chromatin reorganization that occurs 
during the differentiation of mammalian retinal neurons and glia. 
